Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Liabilities ₹18,661 Cr₹14,925 Cr₹13,309 Cr₹17,566 Cr₹15,397 Cr

What is the latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹18,661 Cr based on Mar2026 Consolidated results.
Year Total Liabilities
Mar2026₹18,661 Cr
Mar2025₹14,925 Cr
Mar2024₹13,309 Cr
Mar2023₹17,566 Cr
Mar2022₹15,397 Cr

How is Total Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Liabilities % Change
Mar2026 ₹18,661 Cr
25.03
Mar2025 ₹14,925 Cr
12.15
Mar2024 ₹13,309 Cr
-24.23
Mar2023 ₹17,566 Cr
14.08
Mar2022 ₹15,397 Cr -

Compare Total Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹68,204.9 Cr -1.8% 5.4% 17.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.8%

5.4%

17.8%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses